Author:
Abe Masanori,Maruyama Noriaki,Suzuki Hiroko,Fujii Yuki,Ito Midori,Yoshida Yoshinori,Okada Kazuyoshi,Soma Masayoshi
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine
Reference40 articles.
1. Japanese Society of Hypertension Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertension Res 2009; 32: 4–107.
2. Wong ND, Lopez VA, L’Italien GL, Chen R, Kline S, Franklin S . Inadequate control of hypertension in US adults with cardiovascular disease co morbidities in 2003–2004. Arch Int Med 2007; 167: 2431–2436.
3. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD . The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Eng J Med 1993; 329: 1456–1462.
4. Brenner BM, Cooper MD, De Zeeuw D, Keane WF, Mitch WE, Parving HH et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Eng J Med 2001; 345: 861–869.
5. Lavermann GD, Henning RH, De Jong PE, Navis G, De Zeeuw D . Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria. Am J Kidney Dis 2001; 38: 1381–1384.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献